LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.017783
 39.41 27.76 939 3105 0.3024 0.6777
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 39.41 27.76 151 3105 0.0486 0.2826
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 39.41 27.76 1286 3105 0.4141 0.7570
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 41.11 27.76 912 3331 0.2738 0.6580
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 41.11 27.76 924 3331 0.2774 0.6611
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 41.11 27.76 142 3331 0.0426 0.2666
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 41.11 27.76 1283 3331 0.3851 0.7419
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 42.81 27.76 958 3596 0.2664 0.6564
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 42.81 27.76 969 3596 0.2694 0.6591
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 42.81 27.76 136 3596 0.0378 0.2541
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 42.81 27.76 1286 3596 0.3576 0.7274
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 44.52 27.76 937 3884 0.2412 0.6383
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 44.52 27.76 950 3884 0.2446 0.6415
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 44.52 27.76 146 3884 0.0376 0.2622
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 44.52 27.76 1324 3884 0.3409 0.7197
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 46.22 27.76 1018 4125 0.2468 0.6474
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 46.22 27.76 1031 4125 0.2499 0.6503
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 46.22 27.76 167 4125 0.0405 0.2824
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 46.22 27.76 1322 4125 0.3205 0.7082
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 47.93 27.76 987 4421 0.2232 0.6293
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 47.93 27.76 1005 4421 0.2273 0.6334
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 47.93 27.76 163 4421 0.0369 0.2738
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 47.93 27.76 1399 4421 0.3164 0.7089
MN20160318_Q01
N22
MCF 10A-H2B-mCherry Trametinib
0.017783
 49.63 27.76 1042 4818 0.2163 0.6280
MN20160318_Q01
D08
MCF 10A-H2B-mCherry Trametinib
0.017783
 49.63 27.76 1056 4818 0.2192 0.6309
MN20160318_Q01
D08